Procter & Gamble Health Limited has informed the Exchange regarding Resignation of Mr Lokesh Chandak as Executive Director of the company w.e.f. September 30, 2025.
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Limited has informed the stock exchange about the resignation of Mr. Lokesh Chandak from the position of Executive Director, effective September 30, 2025. The announcement does not specify the reason for his departure. No successor has been named in this filing. Mr. Chandak's exit means the company will lose an executive director from its board, which is part of its top management team.
The departure of an executive director is a notable change in leadership, though the company has not indicated any governance concerns. Investors should watch for further announcements regarding succession and any strategic shifts this may signal. Short-term stock impact is likely muted unless linked to broader leadership or performance issues.